Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Journal of Cell Science
|
November 4, 2016
RHO binding to FAM65A regulates Golgi reorientation during cell migration
Faraz K Mardakheh, Annette Self, Christopher J Marshall
Science (New York, N.Y.)
|
February 21, 2004
Regulation of cell migration by the C2 domain of the tumor suppressor PTEN
Myrto Raftopoulou, Sandrine Etienne-Manneville, Annette Self, et al.
Current Biology : CB
|
October 7, 2008
DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells
Gilles Gadea, Victoria Sanz-Moreno, Annette Self, et al.
Molecular Oncology
|
October 25, 2017
Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor
Steven R Whittaker, Clare Barlow, Mathew P Martin, et al.
Oncogene
|
June 1, 2019
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Steve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Oncogene
|
October 25, 2018
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Steve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Journal of Cell Science
|
November 4, 2016
RHO binding to FAM65A regulates Golgi reorientation during cell migration
Faraz K Mardakheh, Annette Self, Christopher J Marshall
Science (New York, N.Y.)
|
February 21, 2004
Regulation of cell migration by the C2 domain of the tumor suppressor PTEN
Myrto Raftopoulou, Sandrine Etienne-Manneville, Annette Self, et al.
Current Biology : CB
|
October 7, 2008
DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells
Gilles Gadea, Victoria Sanz-Moreno, Annette Self, et al.
Molecular Oncology
|
October 25, 2017
Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor
Steven R Whittaker, Clare Barlow, Mathew P Martin, et al.
Oncogene
|
June 1, 2019
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Steve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Oncogene
|
October 25, 2018
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Steve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Page
of 1